BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yoshikawa R, Fujiwara Y, Koishi K, Kojima S, Matsumoto T, Yanagi H, Yamamura T, Hashimoto-Tamaoki T, Nishigami T, Tsujimura T. Cyclooxygenase-2 expression after preoperative chemoradiotherapy correlates with more frequent esophageal cancer recurrence. World J Gastroenterol 2007; 13(16): 2283-2288 [PMID: 17511025 DOI: 10.3748/wjg.v13.i16.2283]
URL: https://www.wjgnet.com/1007-9327/full/v13/i16/2283.htm
Number Citing Articles
1
Lingyun Wei, Nang Yan, Lei Sun, Chuanen Bao, Demin Li. Interplay between the NF‑κB and hedgehog signaling pathways predicts prognosis in esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapyInternational Journal of Molecular Medicine 2018;  doi: 10.3892/ijmm.2018.3447
2
Bharat B Aggarwal, Prashasnika Gehlot. Inflammation and cancer: how friendly is the relationship for cancer patients?Current Opinion in Pharmacology 2009; 9(4): 351 doi: 10.1016/j.coph.2009.06.020
3
Noemí Eiró, Francisco J Vizoso. Inflammation and cancerWorld Journal of Gastrointestinal Surgery 2012; 4(3): 62-72 doi: 10.4240/wjgs.v4.i3.62
4
Meilan Chen, Erhui Cai, Jizheng Huang, Ping Yu, Ke Li. Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Esophageal Cancer: A Systematic Review and Meta-analysisCancer Epidemiology, Biomarkers & Prevention 2012; 21(7): 1126 doi: 10.1158/1055-9965.EPI-12-0020
5
Reigetsu Yoshikawa, Tohru Tsujimura, Lihua Tao, Norihiko Kamikonya, Yoshinori Fujiwara. The oncoprotein and stem cell renewal factor BMI1 associates with poor clinical outcome in oesophageal cancer patients undergoing preoperative chemoradiotherapyBMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-461
6
Dan Zhao, Xuemei Zhang, Yongli Guo, Wen Tan, Dongxin Lin. Cyclooxygenase‐2 Gly587Arg variant is associated with differential enzymatic activity and risk of esophageal squamous‐cell carcinomaMolecular Carcinogenesis 2009; 48(10): 934 doi: 10.1002/mc.20543
7
Bo Zhang, Chang-Liang Wang, Wen-Hua Zhao, Ming Lv, Chun-Ying Wang, Wei-Xia Zhong, Wu-Yuan Zhou, Wen-Sheng Yu, Yan Zhang, Sheng Li. Effect of 5-LOX/COX-2 common inhibitor DHDMBF30 on pancreatic cancer cell Capan2World Journal of Gastroenterology 2008; 14(16): 2494-2500 doi: 10.3748/wjg.14.2494
8
M.J.D. Prins, R.J.J. Verhage, F.J.W. ten Kate, R. van Hillegersberg. Cyclooxygenase Isoenzyme-2 and Vascular Endothelial Growth Factor are Associated with Poor Prognosis in Esophageal AdenocarcinomaJournal of Gastrointestinal Surgery 2012; 16(5): 956 doi: 10.1007/s11605-011-1814-1
9
Min Kyu Kang, Won Park, Yoon-La Choi, Eun Yoon Cho, Geunghwan Ahn, HeeRim Nam, Seung Jae Huh, Yong Chan Ahn, Do Hoon Lim, Dong Ryul Oh, Duk Soo Bae, Byoung Gie Kim. The Effect of Cyclooxygenase-2 Expression on Tumor Volume Response in Patients Treated with Radiotherapy for Uterine Cervical CancerJournal of Korean Medical Science 2009; 24(6): 1170 doi: 10.3346/jkms.2009.24.6.1170
10
R Yoshikawa, Y Nakano, L Tao, K Koishi, T Matsumoto, M Sasako, T Tsujimura, T Hashimoto-Tamaoki, Y Fujiwara. Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapyBritish Journal of Cancer 2008; 98(10): 1670 doi: 10.1038/sj.bjc.6604361
11
L. LI, J. ZHAO, Z. WU, G. WANG, G. CHEN. Meta‐analysis: clinicopathological and prognostic significance of cyclooxygenase‐2 expression on oesophageal squamous cell carinomaAlimentary Pharmacology & Therapeutics 2009; 30(6): 589 doi: 10.1111/j.1365-2036.2009.04069.x